Pfizer joins Minnesota and Company to discuss how to protect yourself by scheduling your vaccines to prevent serious consequences.
2don MSN
Pfizer shares were rising early Tuesday after the company reported fourth-quarter earnings and revenue that came in ahead of ...
2don MSN
The results cap off a critical year for Pfizer, which has been slashing costs as it recovers from the rapid decline of its ...
Pfizer's fourth quarter beat expectations on strong sales of its Covid vaccine and pill, bolstering its sales as it seeks to ...
Even as GSK’s RSV vaccine launch hits a serious slowdown, the British pharma has dialed up its long-term sales guidance once ...
A jab given to patients to battle RSV through the NHS could potentially cause a disabling condition known as Guillain-Barré ...
GSK was able to offset the decline thanks to a better-than-expected performance for its cancer medicines and HIV therapeutics ...
Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study.
Pfizer posted Q4 revenue of $17.76 billion, up 22% YoY, with strong sales from Paxlovid, Vyndaqel, and Eliquis. The company reaffirmed its 2025 revenue outlook.
One Zelienople child survived a serious health scare after coming down with respiratory syncytial virus in late January. The ...
We recently compiled a list of the 12 Best Dividend Stocks Under $30. In this article, we are going to take a look at where ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback